How Biotech And Pharma Adopt AI And The Supply Chain Opportunities

Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge, so do opportunities in the supply chain.

Read the full story at Forbes AI ↗

Timeline · 1 report

2026-10-02 18:14 · Forbes AI
How Biotech And Pharma Adopt AI And The Supply Chain Opportunities

More stories

NVIDIA DGX Spark 64GB Gives Developers More Ways to Build and Scale Local AI — NVIDIA Blog
Gemini 4 Argon: our next era of frontier intelligence — Google Gemini Blog
Guided Vision in Gemini Live: built for accessibility — Google Gemini Blog
Tavus unveils Griffin, the "first Human Interaction Model", which it says passed the "video Turing test", with 48% of users thinking it was human in live chats (@tavus) — Techmeme
Google tests its plan for AI data centers in space with Project Suncatcher — Scientific American
Google announces Gemini 4 Argon AI model, but you can't use it yet — Ars Technica AI
OpenAI announces ‘dots’ agent after scrapping launch of new AI model over safety concerns — The Guardian AI
OpenAI DevDay 2026 Keynote (FULL) — OpenAI YouTube

Get the daily brief of stories like this at 6:30 every morning →